Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

It's not often a famous composer helps solve a 200-year-old mystery, but DNA from Beethoven's hair might actually do that.

The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

According to WHO, 254 million people globally were estimated to have HBV in 2022, but only approximately 10% had been ...

Virus-specific T-cell measurement is made easier to enable better understanding of immune responses in patients and ...

China: A recent retrospective cohort study has highlighted the significant role of pulmonary infections in influencing ...

Shares of Precision BioSciences DTIL rallied 23.8% on Tuesday after the company’s announcement that the FDA has granted Fast ...